TSHA - Taysha Gene Therapies Inc.

$6.57 as of 2026-07-09 · Healthcare · Biotechnology · Stock

TSHA (Taysha Gene Therapies Inc.) is the #1351 most-held security of 2,507 tracked on Upside Invest, held by 1 retail investor (0% of tracked portfolios), at an average allocation of 2.2% of their portfolio.

• Popularity rank: #1351 of 2,507
• Holders on Upside: 1 retail investor
• Average allocation: 2.2%
• Average holder gain/loss: +33.8%
• 30-day trading activity: 0 buys / 0 sells
• Market cap: $1.3B

Related Healthcare securities: LLY, UNH, HIMS, NVO, PFE

Holder statistics come from anonymized brokerage portfolios connected to Upside Invest. Join to compare your portfolio, or explore all securities.